Chronic phase PH+ chronic myeloid leukemia

Clinical trials for Chronic phase PH+ chronic myeloid leukemia explained in plain language.

Never miss a new study

Get alerted when new Chronic phase PH+ chronic myeloid leukemia trials appear

Sign up with your email to follow new studies for Chronic phase PH+ chronic myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a lower dose of a leukemia drug keep the disease in check?

Disease control Ongoing

This study tests whether reducing the dose of the cancer drug radotinib can still control chronic myeloid leukemia in its early phase while possibly easing side effects. Adults newly diagnosed with this blood cancer take a lower dose twice daily for up to a year. Researchers meas…

Matched conditions: CHRONIC PHASE PH+ CHRONIC MYELOID LEUKEMIA

Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

Chronic phase PH+ chronic myeloid leukemia

Get alerted when new Chronic phase PH+ chronic myeloid leukemia trials appear

Can a lower dose of a leukemia drug keep the disease in check?